Changing therapeutic strategy according to trough level of infliximab and antibodies in children affected by inflammatory bowel disease. (10th October 2016) - Bracci, F.; Tolusso, B.; Tomarchio, S.; Papadatou, B.; Knafelz, D.; Di Sante, G.; Basso, M.S.; Liccardo, D.; Candusso, M.; Pietrobattista, A.; Gremese, E.; Torre, G.